Search results
Results from the WOW.Com Content Network
The more important question is: Why have Inovio's shares fallen for several weeks now?
Before you buy stock in Inovio Pharmaceuticals, consider this: ... dropping from $37.3 million in the second quarter of 2023 to $33.3 million in the second quarter of 2024, an almost 11% decrease. ...
And just like that, the tides have turned for Inovio Pharmaceuticals (INO). Shares of the high-flying biotech dropped last week by 31%, the vast majority of which came after the release of interim ...
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Inovio Pharmaceuticals wasn’t one of them. The 10 stocks that ...
Investors are not impressed with the biotech's latest plan to raise cash.
It’s been a thrilling year of ups and downs for Inovio (NASDAQ:INO). INO stock rocketed as much as 1,000% earlier this year following news that Inovio had a leading candidate in the race for a ...
The heavy selling pressure might have exhausted for Inovio (INO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts ...
Inovio (INO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.